Epidemiological and functional dissection of the co-evolution between Plasmodium falciparum parasites and sickle haemoglobin.

Year of award: 2024

Grantholders

  • Prof Thomas Williams

    Imperial College London, UK

  • Prof Lynette Isabella Oyier

    Kemri-Wellcome Trust Research Programme, Kenya

  • Dr Sophie Uyoga

    Kemri-Wellcome Trust Research Programme, Kenya

  • Prof Thomas Williams

    Imperial College London, UK

  • Dr Abdirahman Abdi

    Kemri-Wellcome Trust Research Programme, Kenya

  • Prof Julian Rayner

    University of Cambridge, United Kingdom

  • Dr Gavin Band

    University of Oxford, United Kingdom

  • Prof Alexandra Rowe

    University of Edinburgh, United Kingdom

Project summary

The "sickle" mutation (HbS; rs334 A>T) in the beta-globin gene (HBB) is the strongest known cause of natural resistance to Plasmodium falciparum malaria. While many mechanisms have been proposed to explain this protection, a recent paradigm-shifting study suggests that these should now be revisited. Through a large case-control study of severe malaria, we discovered that parasites could escape the protective effect of HbS if they carried mutations at specific P. falciparum sickle-associated (Pfsa) genetic loci. Such mutations are common in many African parasite populations, presumably due to HbS-driven natural selection, but the mechanisms by which they allow parasites to evade the protective effects of HbS remain completely unknown. We will discover these functional mechanisms by bringing together an interdisciplinary team of experts from Kenya and the UK to use epidemiological, population-genetic, multi-omic, parasite gene-editing and parasite phenotyping approaches to answer this fundamental question about host-pathogen co-evolution and human malaria resistance. Simultaneously, we will contribute to the development of science in Africa through shared leadership, the training of students, joint working, and technology transfer.